261 related articles for article (PubMed ID: 8567369)
1. Clinical investigation of new animal drugs by veterinary practitioners.
Prater DA; Bertone JJ; Letonja T; Vaughn SD
J Am Vet Med Assoc; 1996 Jan; 208(2):190-4. PubMed ID: 8567369
[No Abstract] [Full Text] [Related]
2. Good clinical practice in clinical drug trials--what you need to know.
Soyebi K; Abosede ; Coker HA; Osuntoki ; Oyibos W; Keri H; Ogunsola S
Nig Q J Hosp Med; 2008; 18(2):104-12. PubMed ID: 19068563
[No Abstract] [Full Text] [Related]
3. Pharma's year of trouble and strife.
Frantz S
Nat Rev Drug Discov; 2006 Jan; 5(1):7-9. PubMed ID: 16485339
[No Abstract] [Full Text] [Related]
4. New office and new leader aim to streamline FDA cancer drug review process.
Twombly R
J Natl Cancer Inst; 2005 May; 97(10):708-9. PubMed ID: 15900036
[No Abstract] [Full Text] [Related]
5. The Food and Drug Administration perspective: use of an investigational drug in a medical emergency.
Schultheis LW; Rappaport BA
Anesth Analg; 2007 Mar; 104(3):479-80. PubMed ID: 17312189
[No Abstract] [Full Text] [Related]
6. Harmonization of regulatory requirements for the development of veterinary clinical trials--a drive toward globalization and simplification.
Alvarez JC; Fortsch GW
Food Drug Law J; 2005; 60(3):407-11. PubMed ID: 16304746
[No Abstract] [Full Text] [Related]
7. Patient group seeks overhaul of FDA clinical trial system in court.
Hede K
J Natl Cancer Inst; 2006 Sep; 98(18):1268-70. PubMed ID: 16985242
[No Abstract] [Full Text] [Related]
8. Investigational new drug, antibiotic, and biological product applications; clinical hold and termination--FDA. Final rule.
Fed Regist; 1992 Apr; 57(73):13244-9. PubMed ID: 10118458
[TBL] [Abstract][Full Text] [Related]
9. Drug development process for a product with a primary pediatric indication.
Allen AJ; Michelson D
J Clin Psychiatry; 2002; 63 Suppl 12():44-9. PubMed ID: 12562061
[TBL] [Abstract][Full Text] [Related]
10. Pediatric drug development in anesthesiology: an FDA perspective.
Schultheis LW; Mathis LL; Roca RA; Simone AF; Hertz SH; Rappaport BA
Anesth Analg; 2006 Jul; 103(1):49-51. PubMed ID: 16790624
[No Abstract] [Full Text] [Related]
11. EU law mandates drug testing in children.
Sinha G
J Natl Cancer Inst; 2008 Jan; 100(2):84-5. PubMed ID: 18182609
[No Abstract] [Full Text] [Related]
12. Current trends in animal law and their implications for the veterinary profession.
Lacroix CA
Vet Clin North Am Small Anim Pract; 2006 Mar; 36(2):341-53, vi. PubMed ID: 16442446
[TBL] [Abstract][Full Text] [Related]
13. Good clinical practice--a practical experience.
Ogunsola FT
Nig Q J Hosp Med; 2008; 18(2):123-4. PubMed ID: 19068567
[No Abstract] [Full Text] [Related]
14. Significant FDA approvals in 1997.
Rheinstein PH; Akbari B
Am Fam Physician; 1998 Jun; 57(11):2865-8. PubMed ID: 9636343
[No Abstract] [Full Text] [Related]
15. Can single-patient investigational new drug studies hurry slow trains to the fast track?
Chenoweth D
Drug Discov Today; 2006 Mar; 11(5-6):185-6. PubMed ID: 16580594
[TBL] [Abstract][Full Text] [Related]
16. Expanded clinical trials of treatments for multiple sclerosis: copolymer 1 (COP-1) treatment investigational new drug (IND) program.
Stark Y
Ann Neurol; 1994 Jul; 36(1):114-5. PubMed ID: 8024251
[No Abstract] [Full Text] [Related]
17. Professional responsibilities.
Jenkins WL
J Am Vet Med Assoc; 1993 May; 202(10):1742-3. PubMed ID: 8514601
[No Abstract] [Full Text] [Related]
18. An update of antidote availability in veterinary medicine.
Post LO; Keller WC
Vet Hum Toxicol; 1999 Aug; 41(4):258-61. PubMed ID: 10434385
[TBL] [Abstract][Full Text] [Related]
19. Maine law requires drug companies to provide clinical trial data.
Appell D
J Natl Cancer Inst; 2005 Sep; 97(17):1246. PubMed ID: 16145043
[No Abstract] [Full Text] [Related]
20. The FDA's drug review process: ensuring drugs are safe and effective.
Meadows M
FDA Consum; 2002; 36(4):19-24. PubMed ID: 12184298
[No Abstract] [Full Text] [Related]
[Next] [New Search]
